Decrease in Proportion of CD19+CD24hiCD27+ B Cells and Impairment of Their Suppressive Function in Graves' Disease

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Zha, Bingbing ^a,b   Wang, Luman ^a   Liu, Xiaoming ^a   Liu, Jun ^a   Chen, Zaoping ^a   Xu, Jiong ^a   Sheng, Li ^a   Li, Yiming ^b   Chu, Yiwei ^a  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; B LYMPHOCYTE; BLOOD CELL; CD19+ CD24HI CD27+ B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL COUNT; CELL DAMAGE; CELL FUNCTION; CELL PROLIFERATION; CELL SUBPOPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; FEMALE; GRAVES DISEASE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INTRACELLULAR SIGNALING; MALE; PATHOGENESIS; PROTEIN SYNTHESIS; RELAPSE;

ADULT; ANTIGENS, CD19; ANTIGENS, CD24; ANTIGENS, CD27; AUTOANTIBODIES; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; FEMALE; GRAVES DISEASE; HUMANS; IMMUNOMODULATION; IMMUNOPHENOTYPING; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PHENOTYPE; YOUNG ADULT;

EID: 84870003475     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049835     Document Type: Article

References (44)

1. Prabhakar BS, Bahn RS, Smith TJ, (2003) Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Endocr Rev 24: 802-835.
2. Rapoport B, McLachlan SM, (2007) The thyrotropin receptor in Graves' disease. Thyroid 17: 911-922.
3. Brent GA, (2008) Clinical practice. Graves' disease. N Engl J Med 358: 2594-2605.
4. Marazuela M, Garcia-Lopez MA, Figueroa-Vega N, de la Fuente H, Alvarado-Sanchez B, et al. (2006) Regulatory T cells in human autoimmune thyroid disease. J Clin Endocrinol Metab 91: 3639-3646.
5. Cooper DS, (2003) Hyperthyroidism. Lancet 362: 459-468.
6. Banga JP, Nielsen CH, Gilbert JA, El Fassi D, Hegedus L, (2008) Application of new therapies in Graves' disease and thyroid-associated ophthalmopathy: animal models and translation to human clinical trials. Thyroid 18: 973-981.
7. Nielsen CH, El Fassi D, Hasselbalch HC, Bendtzen K, Hegedus L, (2007) B-cell depletion with rituximab in the treatment of autoimmune diseases. Graves' ophthalmopathy the latest addition to an expanding family. Expert Opin Biol Ther 7: 1061-1078.
8. El Fassi D, Nielsen CH, Hasselbalch HC, Hegedus L, (2006) The rationale for B lymphocyte depletion in Graves' disease. Monoclonal anti-CD20 antibody therapy as a novel treatment option. Eur J Endocrinol 154: 623-632.
9. El Fassi D, Nielsen CH, Bonnema SJ, Hasselbalch HC, Hegedus L, (2007) B lymphocyte depletion with the monoclonal antibody rituximab in Graves' disease: a controlled pilot study. J Clin Endocrinol Metab 92: 1769-1772.
10. Goetz M, Atreya R, Ghalibafian M, Galle PR, Neurath MF, (2007) Exacerbation of ulcerative colitis after rituximab salvage therapy. Inflamm Bowel Dis 13: 1365-1368.
11. Lehmann-Horn K, Schleich E, Hertzenberg D, Hapfelmeier A, Kumpfel T, et al. (2011) Anti-CD20 B-cell depletion enhances monocyte reactivity in neuroimmunological disorders. J Neuroinflammation 8: 146.
12. Mauri C, Gray D, Mushtaq N, Londei M, (2003) Prevention of arthritis by interleukin 10-producing B cells. J Exp Med 197: 489-501.
13. Matsushita T, Yanaba K, Bouaziz JD, Fujimoto M, Tedder TF, (2008) Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest 118: 3420-3430.
14. Hussain S, Delovitch TL, (2007) Intravenous transfusion of BCR-activated B cells protects NOD mice from type 1 diabetes in an IL-10-dependent manner. J Immunol 179: 7225-7232.
15. Yanaba K, Bouaziz JD, Haas KM, Poe JC, Fujimoto M, et al. (2008) A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 28: 639-650.
16. Tedder TF, Matsushita T, (2010) Regulatory B cells that produce IL-10: a breath of fresh air in allergic airway disease. J Allergy Clin Immunol 125: 1125-1127.
17. Mizoguchi E, Mizoguchi A, Preffer FI, Bhan AK, (2000) Regulatory role of mature B cells in a murine model of inflammatory bowel disease. Int Immunol 12: 597-605.
18. Yanaba K, Yoshizaki A, Asano Y, Kadono T, Tedder TF, et al. (2011) IL-10-producing regulatory B10 cells inhibit intestinal injury in a mouse model. Am J Pathol 178: 735-743.
19. Matsushita T, Horikawa M, Iwata Y, Tedder TF, (2010) Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis. J Immunol 185: 2240-2252.
20. Ren X, Akiyoshi K, Dziennis S, Vandenbark AA, Herson PS, et al. (2011) Regulatory B cells limit CNS inflammation and neurologic deficits in murine experimental stroke. J Neurosci 31: 8556-8563.
21. Blair PA, Norena LY, Flores-Borja F, Rawlings DJ, Isenberg DA, et al. (2010) CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity 32: 129-140.
22. Iwata Y, Matsushita T, Horikawa M, Dilillo DJ, Yanaba K, et al. (2011) Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood 117: 530-541.
23. Pan D, Shin YH, Gopalakrishnan G, Hennessey J, De Groot LJ, (2009) Regulatory T cells in Graves' disease. Clin Endocrinol (Oxf) 71: 587-593.
24. Maseda D, Smith SH, Dilillo DJ, Bryant JM, Candando KM, et al. (2012) Regulatory b10 cells differentiate into antibody-secreting cells after transient IL-10 production in vivo. J Immunol 188: 1036-1048.
25. Sun JB, Czerkinsky C, Holmgren J, (2012) B Lymphocytes Treated In Vitro with Antigen Coupled to Cholera Toxin B Subunit Induce Antigen-Specific Foxp3+ Regulatory T Cells and Protect against Experimental Autoimmune Encephalomyelitis. J Immunol 188: 1686-1697.
26. Bouaziz JD, Calbo S, Maho-Vaillant M, Saussine A, Bagot M, et al. (2010) IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro. Eur J Immunol 40: 2686-2691.
27. Agematsu K, Nagumo H, Yang FC, Nakazawa T, Fukushima K, et al. (1997) B cell subpopulations separated by CD27 and crucial collaboration of CD27+ B cells and helper T cells in immunoglobulin production. Eur J Immunol 27: 2073-2079.
28. Sims GP, Ettinger R, Shirota Y, Yarboro CH, Illei GG, et al. (2005) Identification and characterization of circulating human transitional B cells. Blood 105: 4390-4398.
29. Palanichamy A, Barnard J, Zheng B, Owen T, Quach T, et al. (2009) Novel human transitional B cell populations revealed by B cell depletion therapy. J Immunol 182: 5982-5993.
30. Rehnberg M, Amu S, Tarkowski A, Bokarewa MI, Brisslert M, (2009) Short- and long-term effects of anti-CD20 treatment on B cell ontogeny in bone marrow of patients with rheumatoid arthritis. Arthritis Res Ther 11: R123.
31. Wilson MS, Taylor MD, O'Gorman MT, Balic A, Barr TA, et al. (2010) Helminth-induced CD19+CD23hi B cells modulate experimental allergic and autoimmune inflammation. Eur J Immunol 40: 1682-1696.
32. Kalergis AM, Ravetch JV, (2002) Inducing tumor immunity through the selective engagement of activating Fcgamma receptors on dendritic cells. J Exp Med 195: 1653-1659.
33. Bayry J, Lacroix-Desmazes S, Kazatchkine MD, Hermine O, Tough DF, et al. (2005) Modulation of dendritic cell maturation and function by B lymphocytes. J Immunol 175: 15-20.
34. Kirkland D, Benson A, Mirpuri J, Pifer R, Hou B, et al. (2012) B cell-intrinsic MyD88 signaling prevents the lethal dissemination of commensal bacteria during colonic damage. Immunity 36: 228-238.
35. Weetman AP, Yateman ME, Ealey PA, Black CM, Reimer CB, et al. (1990) Thyroid-stimulating antibody activity between different immunoglobulin G subclasses. J Clin Invest 86: 723-727.
36. Ray A, Basu S, Williams CB, Salzman NH, Dittel BN, (2012) A novel IL-10-independent regulatory role for B cells in suppressing autoimmunity by maintenance of regulatory T cells via GITR ligand. J Immunol 188: 3188-3198.
37. Amu S, Saunders SP, Kronenberg M, Mangan NE, Atzberger A, et al. (2010) Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model. J Allergy Clin Immunol 125: 1114-1124 e1118.
38. Chen X, Jensen PE, (2007) Cutting edge: primary B lymphocytes preferentially expand allogeneic FoxP3+ CD4 T cells. J Immunol 179: 2046-2050.
39. Gonnella PA, Waldner HP, Weiner HL, (2001) B cell-deficient (mu MT) mice have alterations in the cytokine microenvironment of the gut-associated lymphoid tissue (GALT) and a defect in the low dose mechanism of oral tolerance. J Immunol 166: 4456-4464.
40. Parekh VV, Prasad DV, Banerjee PP, Joshi BN, Kumar A, et al. (2003) B cells activated by lipopolysaccharide, but not by anti-Ig and anti-CD40 antibody, induce anergy in CD8+ T cells: role of TGF-beta 1. J Immunol 170: 5897-5911.
41. Sfikakis PP, Boletis JN, Lionaki S, Vigklis V, Fragiadaki KG, et al. (2005) Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down-regulation of the T cell costimulatory molecule CD40 ligand: an open-label trial. Arthritis Rheum 52: 501-513.
42. Xiu Y, Wong CP, Bouaziz JD, Hamaguchi Y, Wang Y, et al. (2008) B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-specific differences in Fc gamma R effector functions. J Immunol 180: 2863-2875.
43. Lemoine S, Morva A, Youinou P, Jamin C, (2011) Human T cells induce their own regulation through activation of B cells. J Autoimmun 36: 228-238.
44. Weetman AP, (2004) Autoimmune thyroid disease. Autoimmunity 37: 337-340.